BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Anticancer prodrugs
,
Fenofibrate
,
rs2230926
,
GATA1
,
Coagulation
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CAGTCAC_MIR134
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Kidney
Fetal brain
Adrenal gland cortex
Pancreas
Aorta
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Alpha-1-antitrypsin deficiency
Vesicular stomatitis Indiana virus disease
Microbial culture finding
Pneumonia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CGP 60474
JM 3100
flavopiridol
AT 7519
BMS 387032
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR122
DROSHA
PPP2R2C
NR5A1
PCDH11X
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Carotid arteries from atherogenic ApoE knockout mice with carotid artery injury
Liver miRNA expression after in vivo miR-122 knockdown
Follicular fluid miRNA profiles during the development of the oocyte
miRNA expression In maintenance and differentiation of human embryonic stem cells
Dendritic cells infected with M. tuberculosis
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for CAGTCAC_MIR134
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for CAGTCAC_MIR134
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ